Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
Shailly Gupta One key concern raised by big pharma at @IFPMA press conference today is related to supply chain. With many countries following a nationalist approach and closing borders, access to raw materials for producing drugs, diagnostics and vaccines may get affected. 03:56 - 19 Mar 2020